{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:57:40Z","timestamp":1789984660901,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s13365-015-0382-7","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T13:46:10Z","timestamp":1443188770000},"page":"170-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients"],"prefix":"10.1007","volume":"22","author":[{"name":"for the CHARTER Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-9913","authenticated-orcid":false,"given":"Qing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Vaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea A.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ting","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin B.","family":"Gelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Morgello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"issue":"18","key":"382_CR1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799","journal-title":"Neurology"},{"key":"382_CR2","unstructured":"Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. World Health Organization. Geneva, Switzerland 2006"},{"key":"382_CR3","volume-title":"Manual for the beck depression inventory-II","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK (1996) Manual for the beck depression inventory-II. Psychological Corporation, San Antonio"},{"issue":"2","key":"382_CR4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jac\/dkq434","volume":"66","author":"BM Best","year":"2011","unstructured":"Best BM, Koopmans PP, Letendre SL et al (2011) Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother 66(2):354\u2013357","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"382_CR5","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s11064-013-1165-2","volume":"38","author":"M Brandmann","year":"2013","unstructured":"Brandmann M, Nehls U, Dringen R (2013) 8-Hydroxy-efavirenz, the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes. Neurochem Res 38(12):2524\u20132534","journal-title":"Neurochem Res"},{"issue":"4","key":"382_CR6","doi-asserted-by":"crossref","first-page":"e95500","DOI":"10.1371\/journal.pone.0095500","volume":"9","author":"LA Brown","year":"2014","unstructured":"Brown LA, Jin J, Ferrell D et al (2014) Efavirenz promotes beta-secretase expression and increased Abeta1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). PLoS One 9(4):e95500","journal-title":"PLoS One"},{"issue":"6","key":"382_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s13365-012-0127-9","volume":"18","author":"T Bunupuradah","year":"2012","unstructured":"Bunupuradah T, Chetchotisakd P, Jirajariyavej S et al (2012) Neurocognitive impairment in patients randomized to second-line lopinavir\/ritonavir-based antiretroviral therapy vs. lopinavir\/ritonavir monotherapy. J Neurovirol 18(6):479\u2013487","journal-title":"J Neurovirol"},{"issue":"9","key":"382_CR8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.aids.0000171409.38490.48","volume":"19","author":"EV Capparelli","year":"2005","unstructured":"Capparelli EV, Holland D, Okamoto C et al (2005) Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. AIDS 19(9):949\u2013952","journal-title":"AIDS"},{"issue":"3","key":"382_CR9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13803390490510031","volume":"26","author":"CL Carey","year":"2004","unstructured":"Carey CL, Woods SP, Gonzalez R et al (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26(3):307\u2013319","journal-title":"J Clin Exp Neuropsychol"},{"issue":"8","key":"382_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/01.WNL.0000158328.26897.0D","volume":"64","author":"M Cherner","year":"2005","unstructured":"Cherner M, Letendre S, Heaton RK et al (2005) Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64(8):1343\u20131347","journal-title":"Neurology"},{"issue":"16","key":"382_CR11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","volume":"76","author":"N Ciccarelli","year":"2011","unstructured":"Ciccarelli N, Fabbiani M, Di Giambenedetto S et al (2011) Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 76(16):1403\u20131409","journal-title":"Neurology"},{"issue":"10","key":"382_CR12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-143-10-200511150-00008","volume":"143","author":"DB Clifford","year":"2005","unstructured":"Clifford DB, Evans S, Yang Y et al (2005) Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 143(10):714\u2013721","journal-title":"Ann Intern Med"},{"issue":"6","key":"382_CR13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1310\/hct1006-343","volume":"10","author":"DB Clifford","year":"2009","unstructured":"Clifford DB, Evans S, Yang Y, Acosta EP, Ribaudo H, Gulick RM (2009) Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clin Trials 10(6):343\u2013355","journal-title":"HIV Clin Trials"},{"issue":"1","key":"382_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrn2040","volume":"8","author":"R Ellis","year":"2007","unstructured":"Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8(1):33\u201344","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"382_CR15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","volume":"142","author":"NF Fletcher","year":"2012","unstructured":"Fletcher NF, Wilson GK, Murray J et al (2012) Hepatitis C virus infects the endothelial cells of the blood\u2013brain barrier. Gastroenterology 142(3):634\u2013643, e6","journal-title":"Gastroenterology"},{"issue":"7","key":"382_CR16","doi-asserted-by":"crossref","first-page":"e38980","DOI":"10.1371\/journal.pone.0038980","volume":"7","author":"LJ Garvey","year":"2012","unstructured":"Garvey LJ, Pavese N, Ramlackhansingh A et al (2012) Acute HCV\/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation. PLoS One 7(7):e38980","journal-title":"PLoS One"},{"issue":"11","key":"382_CR17","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/497835","volume":"41","author":"F Gutierrez","year":"2005","unstructured":"Gutierrez F, Navarro A, Padilla S et al (2005) Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring. Clin Infect Dis 41(11):1648\u20131653","journal-title":"Clin Infect Dis"},{"issue":"23","key":"382_CR18","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75(23):2087\u20132096","journal-title":"Neurology"},{"issue":"2","key":"382_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11481-009-9155-5","volume":"4","author":"T Ikezu","year":"2009","unstructured":"Ikezu T (2009) The aging of human-immunodeficiency-virus-associated neurocognitive disorders. J NeuroImmune Pharm 4(2):161\u2013162","journal-title":"J NeuroImmune Pharm"},{"issue":"Suppl 1","key":"382_CR20","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00002030-200401001-00008","volume":"18","author":"AC Justice","year":"2004","unstructured":"Justice AC, McGinnis KA, Atkinson JH et al (2004) Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: veterans aging cohort five-site study. AIDS 18(Suppl 1):S49\u2013S59","journal-title":"AIDS"},{"key":"382_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2377-10-60","volume":"10","author":"GD Kanmogne","year":"2010","unstructured":"Kanmogne GD, Kuate CT, Cysique LA et al (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 10:60","journal-title":"BMC Neurol"},{"issue":"6831","key":"382_CR22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410(6831):988\u2013994","journal-title":"Nature"},{"issue":"4","key":"382_CR23","first-page":"137","volume":"19","author":"S Letendre","year":"2011","unstructured":"Letendre S (2011) Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 19(4):137\u2013142","journal-title":"Top Antivir Med"},{"issue":"Suppl 3","key":"382_CR24","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/01.aids.0000192073.18691.ff","volume":"19","author":"SL Letendre","year":"2005","unstructured":"Letendre SL, Cherner M, Ellis RJ et al (2005) The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 19(Suppl 3):S72\u2013S78","journal-title":"AIDS"},{"key":"382_CR25","unstructured":"Letendre S, Croteau D, Ellis Ret al. Lower CSAR are associated with global neurocognitive impairment in antiretroviral-treated people with HIV. In: 18th Conference on Retroviruses and Opportunistic Infections. Boston, MA, 2011: Abstract 408"},{"issue":"2","key":"382_CR26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0000000000000008","volume":"65","author":"MJ Marquine","year":"2014","unstructured":"Marquine MJ, Umlauf A, Rooney AS et al (2014) The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr 65(2):190\u2013197","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"382_CR27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/13854046.2012.680912","volume":"26","author":"EE Morgan","year":"2012","unstructured":"Morgan EE, Woods SP, Rooney A, Perry W, Grant I, Letendre SL (2012) Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk. Clin Neuropsychol 26(4):654\u2013674","journal-title":"Clin Neuropsychol"},{"issue":"5","key":"382_CR28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","volume":"18","author":"K Robertson","year":"2012","unstructured":"Robertson K, Liner J, Meeker RB (2012a) Antiretroviral neurotoxicity. J Neurovirol 18(5):388\u2013399","journal-title":"J Neurovirol"},{"issue":"6","key":"382_CR29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/cid\/cis507","volume":"55","author":"K Robertson","year":"2012","unstructured":"Robertson K, Jiang H, Kumwenda J et al (2012b) Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis 55(6):868\u2013876","journal-title":"Clin Infect Dis"},{"issue":"2","key":"382_CR30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1212\/01.wnl.0000225183.74521.72","volume":"67","author":"N Sacktor","year":"2006","unstructured":"Sacktor N, Nakasujja N, Skolasky R et al (2006) Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67(2):311\u2013314","journal-title":"Neurology"},{"issue":"7","key":"382_CR31","doi-asserted-by":"crossref","first-page":"e70201","DOI":"10.1371\/journal.pone.0070201","volume":"8","author":"JR Santos","year":"2013","unstructured":"Santos JR, Munoz-Moreno JA, Molto J et al (2013) Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir\/ritonavir: an exploratory study. PLoS One 8(7):e70201","journal-title":"PLoS One"},{"issue":"10","key":"382_CR32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1469-0691.2010.03176.x","volume":"16","author":"A Thiyagarajan","year":"2010","unstructured":"Thiyagarajan A, Garvey LJ, Pflugrad H et al (2010) Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection. Clin Microbiol Infect 16(10):1579\u20131584","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"382_CR33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.112.195701","volume":"343","author":"LB Tovar-y-Romo","year":"2012","unstructured":"Tovar-y-Romo LB, Bumpus NN, Pomerantz D et al (2012) Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther 343(3):696\u2013703","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"382_CR34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/cir524","volume":"53","author":"V Valcour","year":"2011","unstructured":"Valcour V, Paul R, Chiao S, Wendelken LA, Miller B (2011) Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis 53(8):836\u2013842","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"382_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2011.08.025","volume":"312","author":"P Vivithanaporn","year":"2012","unstructured":"Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ, Power C (2012) Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV\/AIDS. J Neurol Sci 312(1\u20132):45\u201351","journal-title":"J Neurol Sci"},{"issue":"6","key":"382_CR36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2893.2009.01198.x","volume":"17","author":"A Winston","year":"2010","unstructured":"Winston A, Garvey L, Scotney E et al (2010) Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals? J Viral Hepat 17(6):419\u2013426","journal-title":"J Viral Hepat"},{"issue":"7","key":"382_CR37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/QAD.0b013e3283454c74","volume":"25","author":"A Winston","year":"2011","unstructured":"Winston A, Garvey L, Sabin CA (2011) Superior neurocognitive function is associated with central nervous system antiretroviral drug penetration only in regimens containing more than three antiretroviral agents. AIDS 25(7):1014\u20131015","journal-title":"AIDS"},{"issue":"4","key":"382_CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1293.2011.00962.x","volume":"13","author":"A Winston","year":"2012","unstructured":"Winston A, Puls R, Kerr SJ et al (2012) Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study. HIV Med 13(4):245\u2013251","journal-title":"HIV Med"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-015-0382-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0382-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T10:47:05Z","timestamp":1718102825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-015-0382-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s13365-015-0382-7","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]}}}